• The Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has initiated a formal review of aluminum adjuvants in vaccines, focusing on potential links to allergies and other conditions.
  • The move has been met with immediate pushback from the scientific community, which points to large-scale studies finding no such link and a recent decline in childhood food allergy rates.
  • The review signals a significant shift in federal vaccine policy and has introduced new uncertainty into the public health and biotech sectors.

Efforts by the Department of Health and Human Services to reassess the safety of common vaccine ingredients have hit a snag with the scientific establishment, setting the stage for a contentious policy debate. Secretary Robert F. Kennedy Jr. has directed advisers to review whether aluminum compounds used as adjuvants in vaccines are causing allergies in children, according to people familiar with the matter.

The core of the review centers on claims that aluminum adjuvants are neurotoxic and linked to conditions like autism, asthma, and food allergies. In a significant departure from previous administration stances, the Centers for Disease Control and Prevention updated its website language in November 2025, stating that studies have not "definitively ruled out" a link between vaccines and autism. The Advisory Committee on Immunization Practices has scheduled a discussion of "adjuvants and contaminants" on its draft agenda, confirming the policy pivot is underway.

However, the scientific evidence presented to counter these claims is substantial. A large Danish study published in the Annals of Internal Medicine, which examined 1.2 million children over decades, found no significant risk of autoimmune, allergic, or neurodevelopmental disorders from aluminum in vaccines. When Kennedy's office demanded the retraction of this study in August 2025, calling it a "deceitful propaganda stunt," the journal refused. Independent virologist Gary Grohmann noted the aluminum-autism link has been "debunked again and again."

The allergy evidence presents a particular problem for the review's premise. Recent data shows food allergy rates among American children declined significantly from approximately 1.5 percent in 2015 to 0.9 percent in 2020—a drop of more than 33 percent. This contradicts the theory of a vaccine-driven allergy surge. Immunologists point out there is no plausible biological mechanism for aluminum adjuvants to create food allergies "out of thin air," as vaccines contain no food proteins. The only documented reaction is an extremely rare localized itchy nodule at the injection site.

Kennedy's push extends beyond the scientific debate; it represents a broader strategy to challenge the vaccine injury compensation system and foster uncertainty, reflecting his longstanding position before entering public office. The HHS did not immediately respond to a request for comment on the timeline or specific endpoints of the review. For now, the move has introduced a new layer of regulatory risk for vaccine manufacturers and has public health officials watching closely as the ACIP prepares to examine the evidence.

Correction: An earlier version of this article misstated the year of the Danish study's publication. It was published prior to the August 2025 retraction request.